OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents
Fanny Mathias, Anita Cohen, Youssef Kabri, et al.
European Journal of Medicinal Chemistry (2020) Vol. 191, pp. 112146-112146
Open Access | Times Cited: 10
Fanny Mathias, Anita Cohen, Youssef Kabri, et al.
European Journal of Medicinal Chemistry (2020) Vol. 191, pp. 112146-112146
Open Access | Times Cited: 10
Showing 10 citing articles:
Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships
Ojasvi Gupta, Tathagata Pradhan, Rohit Bhatia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113606-113606
Closed Access | Times Cited: 31
Ojasvi Gupta, Tathagata Pradhan, Rohit Bhatia, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113606-113606
Closed Access | Times Cited: 31
New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi , the causative agent of Chagas disease
Silvane Maria Fonseca Murta, Pedro Augusto Lemos Santana, Thibault Joseph William Jacques Dit Lapierre, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 741-753
Closed Access | Times Cited: 3
Silvane Maria Fonseca Murta, Pedro Augusto Lemos Santana, Thibault Joseph William Jacques Dit Lapierre, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 741-753
Closed Access | Times Cited: 3
Nitro compounds against trypanosomatidae parasites: Heroes or villains?
Paulo Fernando da Silva Santos-Júnior, Leandro Rocha Silva, Lucindo José Quintans‐Júnior, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 75, pp. 128930-128930
Closed Access | Times Cited: 13
Paulo Fernando da Silva Santos-Júnior, Leandro Rocha Silva, Lucindo José Quintans‐Júnior, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 75, pp. 128930-128930
Closed Access | Times Cited: 13
Chagas Disease Chemotherapy: What Do We Know So Far?
Aline Araújo Zuma, Wanderley de Souza
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 3963-3995
Closed Access | Times Cited: 16
Aline Araújo Zuma, Wanderley de Souza
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 3963-3995
Closed Access | Times Cited: 16
Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases
Hollis D. Showalter
Molecules (2020) Vol. 25, Iss. 18, pp. 4137-4137
Open Access | Times Cited: 14
Hollis D. Showalter
Molecules (2020) Vol. 25, Iss. 18, pp. 4137-4137
Open Access | Times Cited: 14
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification
Gideon D. Badenhorst, Christina Kannigadu, Janine Aucamp, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 176, pp. 106242-106242
Open Access | Times Cited: 6
Gideon D. Badenhorst, Christina Kannigadu, Janine Aucamp, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 176, pp. 106242-106242
Open Access | Times Cited: 6
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
Vincent Montero, Marc Montana, Omar Khoumeri, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 781-781
Open Access | Times Cited: 5
Vincent Montero, Marc Montana, Omar Khoumeri, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 781-781
Open Access | Times Cited: 5
Design and synthesis of imidazo[1,2‐a]pyridine‐chalcone conjugates as antikinetoplastid agents
Devesh S. Agarwal, Richard M. Beteck, Kayhan Ilbeigi, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Open Access | Times Cited: 2
Devesh S. Agarwal, Richard M. Beteck, Kayhan Ilbeigi, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Open Access | Times Cited: 2
Identification of Novel Antileishmanial Chemotypes By High-Throughput Virtual and In Vitro Screening
Huma Khan, Mohammed Ageeli Hakami, Mubarak A. Alamri, et al.
Acta Parasitologica (2024) Vol. 69, Iss. 3, pp. 1439-1457
Closed Access
Huma Khan, Mohammed Ageeli Hakami, Mubarak A. Alamri, et al.
Acta Parasitologica (2024) Vol. 69, Iss. 3, pp. 1439-1457
Closed Access
Evaluation of 2,3-Dihydroimidazo[2,1- b ]oxazole and Imidazo[2,1– b ]oxazole Derivatives As Chemotherapeutic Agents
Afnan I. Shahin, Seyed–Omar Zaraei, Shahed Alzuraiqi, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 20, pp. 1885-1901
Closed Access | Times Cited: 1
Afnan I. Shahin, Seyed–Omar Zaraei, Shahed Alzuraiqi, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 20, pp. 1885-1901
Closed Access | Times Cited: 1
